Taiwan Bio Therapeutics (ROCO:6892) ROE % Adjusted to Book Value : -21.40% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics ROE % Adjusted to Book Value?

Taiwan Bio Therapeutics's ROE % for the quarter that ended in Jun. 2024 was -73.61%. Taiwan Bio Therapeutics's PB Ratio for the quarter that ended in Jun. 2024 was 3.44. Taiwan Bio Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -21.40%.

Taiwan Bio Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Taiwan Bio Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics ROE % Adjusted to Book Value Chart

Taiwan Bio Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-15.48

-11.09

Taiwan Bio Therapeutics Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-	-22.06	-24.90	-15.94	-21.40

Competitive Comparison of Taiwan Bio Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Taiwan Bio Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiwan Bio Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Taiwan Bio Therapeutics ROE % Adjusted to Book Value Calculation

Taiwan Bio Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-38.16%	/	3.44
	=	-11.09%

Taiwan Bio Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-73.61%	/	3.44
	=	-21.40%

Taiwan Bio Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744

Website

https://www.twbio-thera.com

Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines